Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_51285 | 53 | 1.10 | Mlig455_036196 | Neo: - Age: - |
Mlig455_036196 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_62519} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -6.185 | 1.43 | 0.99958 | 1.00000 | |
RegionR2 | 4.684 | 1.43 | 0.16653 | 0.51083 | |
RegionR3 | 2.355 | 1.43 | 0.27451 | 0.81900 | |
RegionR4 | -0.475 | 1.43 | 0.76544 | 1.00000 | |
RegionR5 | 0.667 | 1.43 | 0.48789 | 0.85132 | |
RegionR6 | 0.349 | 1.43 | 0.99944 | 1.00000 | |
RegionR7 | -0.157 | 1.43 | 1.00000 | 1.00000 | |
RegionR8 | -1.237 | 1.43 | 0.99962 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 3.712 | 1.43 | 0.99975 | 1.00000 | |
RegenerationR2 | 1.55 | 1.43 | 0.63568 | 0.92976 | |
RegenerationR3 | 3.967 | 1.43 | 0.24128 | 0.67602 | |
RegenerationR4 | 4.654 | 1.43 | 0.20223 | 0.64842 | |
RegenerationR5 | 3.807 | 1.43 | 0.25019 | 0.68375 | |
RegenerationR6 | 5.877 | 1.43 | 0.09616 | 0.38563 | |
RegenerationBL | 4.855 | 1.43 | 0.08548 | 0.34262 | |
RegenerationTP | 5.451 | 1.43 | 0.15123 | 0.57591 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_51285 | 53 | 1.1 | Mlig455_036196 | Neo: - Age: - |
3 | - | - | - | 1.000 | 1.000 | 1.000 | Mlig455_036196 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_62519} | |
2. | MligTC455_19119 | 48 | 0.99 | Mlig455_060984 | Neo: - Age: - |
1.769 | - | - | - | - | 0.814 | 0.955 | Mlig455_060984 {REF} {Length: 533} {NoTransDecoderORF} {RNA1509_52549} | |
3. | MligTC455_29697 | 30 | 0.62 | Mlig455_061221 | Neo: - Age: - |
ANKRD28 | 1.742 | - | - | - | - | 0.788 | 0.954 | Mlig455_061221 {REF} {Length: 6142} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=96.9]; Ankyrin repeats (many copies) [PF13637.8, score=73.2]; Ankyrin repeat [PF13606.8, score=60.5]; Ankyrin repeat [PF00023.32, score=48.5]; Ankyrin repeats (many copies) [PF13857.8, score=47.6]; Mab-21 protein [PF03281.16, score=38.6]; Transcription factor BRX N-terminal domain [PF13713.8, score=20.4]} {Human: ENSG00000206560, ANKRD28, ankyrin repeat domain 28, [Score=85.5, Expect=4e-16]} {Mouse: ENSMUSG00000014496, Ankrd28, ankyrin repeat domain 28, [Score=84.0, Expect=1e-15]; ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=83.2, Expect=2e-15]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=78.2, Expect=5e-14]} {Celegans: WBGene00012124, T28D6.4, [Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_11663_0_4, dd_Smed_v6_11663_0_4, [Score=69.3, Expect=1e-11]} {RNA1509_27730} {RNA1310_4721, RNA1509_27730} {RNA1509_27730, RNA815_2426.1} |
4. | MligTC455_51549 | 114 | 2.37 | Mlig455_039237 | Neo: - Age: Down-Down-Up Regeneration-upregulated TP: 6.202 Regeneration-enriched TP: 6.202 |
1.723 | - | - | - | 0.965 | - | 0.758 | Mlig455_039237 {REF} {Length: 3108} {RNA1509_28709} {RNA1310_23779.2} {RNA815_36053} | |
5. | MligTC455_44993 | 102 | 2.13 | Mlig455_068082 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.499 Region-enriched R4: 3.035/0.03492 |
MEN1 | 1.658 | - | - | - | 0.706 | - | 0.952 | Mlig455_068082 {REF} {Length: 4679} {TRANSSPLICED} {Pfam: Menin [PF05053.15, score=359.0]} {Human: ENSG00000133895, MEN1, menin 1, [RH, Score=259, Expect=6e-77]} {Mouse: ENSMUSG00000024947, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]; ENSMUSG00000106695, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]} {Dmel: FBgn0031885, Mnn1, Menin 1, [RH, Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_11544_0_1, dd_Smed_v6_11544_0_1, [RH, Score=206, Expect=2e-56]} {RNA1509_25186} {RNA1310_10581.1} {RNA815_3602} |
6. | MligTC455_41083 | 27 | 0.57 | Mlig455_034126 | Neo: - Age: - |
0.98 | - | - | - | - | - | 0.980 | Mlig455_034126 {REF} {Length: 1904} {NoTransDecoderORF} {RNA1310_47812} {RNA815_46461} | |
7. | MligTC455_08198 | 26 | 0.55 | Mlig455_045449 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_045449 {REF} {Length: 411} {RNA1310_123580} {RNA815_47103} | |
8. | MligTC455_37028 | 269 | 5.6 | Mlig455_069655 | Neo: - Age: - |
0.972 | - | - | - | 0.972 | - | - | Mlig455_069655 {REF} {Length: 5345} {Pfam: CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.2]} {RNA1509_36341, RNA1509_40918} {RNA1310_3370.1, RNA1509_40918} {RNA1509_40918, RNA815_721.1} | |
9. | MligTC455_38261 | 206 | 4.29 | Mlig455_011310, Mlig455_011399 | Neo: - Age: - |
0.971 | - | - | - | 0.971 | - | - | Mlig455_011310 {REF} {Length: 3015} {Pfam: Myb-like DNA-binding domain [PF00249.33, score=22.6]; Myb-like DNA-binding domain [PF13921.8, score=22.4]} {Smed: dd_Smed_v6_10162_0_1, dd_Smed_v6_10162_0_1, [RH, Score=52.0, Expect=4e-07]} {RNA1509_22660} {RNA1310_12928.1} {RNA815_6845.1} Mlig455_011399 {REF} {Length: 3506} {Pfam: Myb-like DNA-binding domain [PF00249.33, score=23.0]; Myb-like DNA-binding domain [PF13921.8, score=22.8]} {Smed: dd_Smed_v6_10162_0_1, dd_Smed_v6_10162_0_1, [Score=51.2, Expect=7e-07]} {RNA1509_22660} {RNA1310_12928.1, RNA1509_22660} {RNA1509_22660, RNA815_18634} |
|
10. | MligTC455_44421 | 36 | 0.74 | Mlig455_016824 | Neo: - Age: - |
0.969 | - | - | - | - | - | 0.969 | Mlig455_016824 {REF} {Length: 717} {NoTransDecoderORF} {RNA1310_130476} | |
11. | MligTC455_24578 | 43 | 0.89 | Mlig455_008110 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.140/0.00102 |
NR1I2 | 0.967 | - | - | - | - | - | 0.967 | Mlig455_008110 {REF} {Length: 8644} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=70.7]} {Human: ENSG00000144852, NR1I2, nuclear receptor subfamily 1 group I member 2, [Score=86.7, Expect=2e-17]; ENSG00000196482, ESRRG, estrogen related receptor gamma, [Score=82.4, Expect=4e-16]; ENSG00000025434, NR1H3, nuclear receptor subfamily 1 group H member 3, [Score=82.4, Expect=1e-16]} {Mouse: ENSMUSG00000022809, Nr1i2, nuclear receptor subfamily 1, group I, member 2, [Score=87.4, Expect=6e-18]} {Dmel: FBgn0000546, EcR, Ecdysone receptor, [Score=84.3, Expect=1e-16]} {Celegans: WBGene00000908, daf-12, Nuclear hormone receptor family member daf-12, [Score=86.7, Expect=2e-17]} {Smed: dd_Smed_v6_5200_0_1, dd_Smed_v6_5200_0_1, [Score=102, Expect=6e-23]} {RNA1509_57652} {RNA1310_76616} {RNA815_39680} |
12. | MligTC455_13884 | 50 | 1.04 | Mlig455_038162, Mlig455_038210 | Neo: - Age: - Region-enriched R4: 6.524/0.00005 |
0.966 | - | - | - | 0.966 | - | - | Mlig455_038162 {REF} {Length: 1003} {RNA1310_47543} {RNA815_24825} Mlig455_038210 {REF} {Length: 1009} {RNA1310_47543} {RNA815_24825} |
|
13. | MligTC455_20109 | 200 | 4.16 | Mlig455_066442 | Neo: - Age: - |
COMMD2 | 0.966 | - | - | - | 0.966 | - | - | Mlig455_066442 {REF} {Length: 1058} {Pfam: COMM domain [PF07258.16, score=36.8]} {Human: ENSG00000114744, COMMD2, COMM domain containing 2, [Score=64.7, Expect=6e-14]} {Mouse: ENSMUSG00000036513, Commd2, COMM domain containing 2, [Score=69.7, Expect=4e-16]} {Smed: dd_Smed_v6_3157_0_1, dd_Smed_v6_3157_0_1, [RH, Score=63.5, Expect=6e-14]} {RNA1509_29317, RNA1509_59169} {RNA1310_26130, RNA1509_29317} {RNA1509_29317, RNA815_16898} |
14. | MligTC455_11171 | 38 | 0.79 | Mlig455_032767 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_032767 {REF} {Length: 428} {TRANSSPLICED} | |
15. | MligTC455_17377 | 32 | 0.67 | Mlig455_041286 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_041286 {REF} {Length: 912} {NoTransDecoderORF} {RNA1310_106511} | |
16. | MligTC455_08061 | 14 | 0.29 | Mlig455_062790 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_062790 {REF} {Length: 604} {NoTransDecoderORF} {RNA1310_101890} | |
17. | MligTC455_34066 | 149 | 3.1 | Mlig455_069292 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_069292 {REF} {Length: 832} {NoTransDecoderORF} {RNA1509_20753} {RNA1310_16791} {RNA815_12674.1} | |
18. | MligTC455_48591 | 25 | 0.53 | Mlig455_047514, Mlig455_059649 | Neo: - Age: - |
NEUROD1 | 0.961 | - | - | - | - | - | 0.961 | Mlig455_047514 {REF} {Length: 1271} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=54.8]; Neuronal helix-loop-helix transcription factor [PF12533.10, score=51.0]} {Human: ENSG00000162992, NEUROD1, neuronal differentiation 1, [Score=140, Expect=1e-38]; ENSG00000164600, NEUROD6, neuronal differentiation 6, [Score=136, Expect=1e-37]} {Mouse: ENSMUSG00000034701, Neurod1, neurogenic differentiation 1, [Score=139, Expect=1e-38]; ENSMUSG00000037984, Neurod6, neurogenic differentiation 6, [Score=133, Expect=1e-36]} {Dmel: FBgn0010433, ato, atonal, [Score=82.0, Expect=8e-18]} {Celegans: WBGene00000561, cnd-1, Neurogenic differentiation factor 1, [Score=127, Expect=6e-36]} {Smed: dd_Smed_v6_21717_0_1, dd_Smed_v6_21717_0_1, [RH, Score=136, Expect=2e-39]} {RNA1310_133631} {RNA815_38093} Mlig455_059649 {REF} {Length: 945} {Pfam: Neuronal helix-loop-helix transcription factor [PF12533.10, score=20.2]} {RNA1310_133631} {RNA815_38093} |
19. | MligTC455_33089 | 33 | 0.69 | Mlig455_016570 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_016570 {REF} {Length: 1723} {RNA1509_27637} {RNA1310_33309} {RNA815_11183} | |
20. | MligTC455_18987 | 99 | 2.07 | Mlig455_049864 | Neo: - Age: Down-Up-Down |
SYN1 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_049864 {REF} {Length: 2522} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=235.1]; Synapsin, N-terminal domain [PF02078.18, score=137.6]} {Human: ENSG00000008056, SYN1, synapsin I, [RH, Score=323, Expect=4e-102]; ENSG00000185666, SYN3, synapsin III, [RH, Score=322, Expect=1e-102]; ENSG00000157152, SYN2, synapsin II, [RH, Score=322, Expect=1e-102]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [RH, Score=328, Expect=4e-105]; ENSMUSG00000037217, Syn1, synapsin I, [RH, Score=325, Expect=6e-103]; ENSMUSG00000009394, Syn2, synapsin II, [RH, Score=322, Expect=4e-104]} {Dmel: FBgn0004575, Syn, Synapsin, [RH, Score=322, Expect=1e-98]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=164, Expect=2e-44]} {Smed: dd_Smed_v6_3135_0_1, dd_Smed_v6_3135_0_1, [RH, Score=390, Expect=4e-129]} {RNA1509_58931} {RNA1310_22468.1} {RNA815_2386} |
21. | MligTC455_25567 | 31 | 0.65 | Mlig455_003495, Mlig455_015560, Mlig455_037973 | Neo: - Age: - |
GLRA4 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_003495 {REF} {Length: 2067} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431} Mlig455_015560 {REF} {Length: 1799} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431} Mlig455_037973 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.4]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.5, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=57.4, Expect=2e-08]} {Mouse: ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.5, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_2, dd_Smed_v6_14925_0_2, [Score=554, Expect=0.0]} {RNA1310_35073.2} {RNA815_40431} |
22. | MligTC455_32033 | 79 | 1.65 | Mlig455_050881 | Neo: - |
MAPK14 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_050881 {REF} {Length: 2379} {Pfam: Protein kinase domain [PF00069.27, score=60.5]} {Human: ENSG00000112062, MAPK14, mitogen-activated protein kinase 14, [Score=92.4, Expect=1e-21]; ENSG00000050748, MAPK9, mitogen-activated protein kinase 9, [Score=91.3, Expect=3e-21]; ENSG00000156711, MAPK13, mitogen-activated protein kinase 13, [Score=88.2, Expect=4e-20]} {Mouse: ENSMUSG00000053436, Mapk14, mitogen-activated protein kinase 14, [Score=92.0, Expect=1e-21]; ENSMUSG00000020366, Mapk9, mitogen-activated protein kinase 9, [Score=91.3, Expect=2e-21]} {Dmel: FBgn0024846, p38b, p38b MAP kinase, [Score=90.5, Expect=3e-21]} {Celegans: WBGene00004055, pmk-1, Mitogen-activated protein kinase pmk-1, [Score=86.3, Expect=6e-20]} {Smed: dd_Smed_v6_6042_0_1, dd_Smed_v6_6042_0_1, [Score=87.8, Expect=1e-20]} {RNA1509_37050} {RNA1310_4000} {RNA815_17615} |
23. | MligTC455_17296 | 134 | 2.79 | Mlig455_037848 | Neo: - |
PIGW | 0.956 | - | - | - | - | - | 0.956 | Mlig455_037848 {REF} {Length: 2875} {Pfam: GWT1 [PF06423.14, score=77.4]} {Human: ENSG00000277161, PIGW, phosphatidylinositol glycan anchor biosynthesis class W, [Score=92.4, Expect=4e-19]; ENSG00000275600, PIGW, phosphatidylinositol glycan anchor biosynthesis class W, [Score=92.4, Expect=4e-19]} {Mouse: ENSMUSG00000045140, Pigw, phosphatidylinositol glycan anchor biosynthesis, class W, [Score=107, Expect=4e-24]} {Dmel: FBgn0031422, PIG-Wa, Phosphatidylinositol glycan anchor biosynthesis class W a, [Score=117, Expect=4e-28]} {Celegans: WBGene00022447, hpo-20, Phosphatidylinositol-glycan biosynthesis class W protein, [Score=97.1, Expect=4e-21]} {Smed: dd_Smed_v6_14190_0_1, dd_Smed_v6_14190_0_1, [Score=96.3, Expect=3e-21]} {RNA1509_28166} {RNA1310_42427} {RNA815_4044} |
24. | MligTC455_37758 | 146 | 3.04 | Mlig455_062274 | Neo: - Age: - |
0.955 | - | - | - | 0.955 | - | - | Mlig455_062274 {REF} {Length: 1295} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_49604} {RNA1310_37277} {RNA815_17792} | |
25. | MligTC455_06578 | 32 | 0.67 | Mlig455_026520, Mlig455_026620 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_026520 {REF} {Length: 631} {NoTransDecoderORF} Mlig455_026620 {REF} {Length: 2186} {RNA1509_4420} {RNA1310_2560} {RNA815_2113.1} |
|
26. | MligTC455_18247 | 30 | 0.63 | Mlig455_064217 | Neo: - Age: - |
RASEF | 0.954 | - | - | - | - | - | 0.954 | Mlig455_064217 {REF} {Length: 2591} {Pfam: Ras family [PF00071.24, score=148.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=96.7]; ADP-ribosylation factor family [PF00025.23, score=52.9]; EF-hand domain pair [PF13499.8, score=33.8]; EF-hand domain [PF13405.8, score=31.5]; EF hand [PF00036.34, score=30.7]; 50S ribosome-binding GTPase [PF01926.25, score=23.7]; Elongation factor Tu GTP binding domain [PF00009.29, score=23.0]; EF hand [PF13202.8, score=20.1]; EF-hand domain pair [PF13833.8, score=18.9]} {Human: ENSG00000165105, RASEF, RAS and EF-hand domain containing, [Score=172, Expect=1e-44]; ENSG00000130038, CRACR2A, calcium release activated channel regulator 2A, [Score=169, Expect=2e-43]} {Mouse: ENSMUSG00000043003, Rasef, RAS and EF hand domain containing, [Score=180, Expect=5e-48]} {Dmel: FBgn0005586, Rab3, [Score=129, Expect=8e-34]} {Celegans: WBGene00016344, rsef-1, Ras and EF-hand domain-containing protein homolog, [Score=174, Expect=7e-46]} {Smed: dd_Smed_v6_12567_0_1, dd_Smed_v6_12567_0_1, [Score=207, Expect=8e-58]} {RNA1310_62867} |
27. | MligTC455_23606 | 40 | 0.83 | Mlig455_045820 | Neo: - |
ANK2 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_045820 {REF} {Length: 6904} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=588.6]; Ankyrin repeats (many copies) [PF13637.8, score=559.7]; Ankyrin repeat [PF13606.8, score=378.6]; Ankyrin repeats (many copies) [PF13857.8, score=364.4]; Ankyrin repeat [PF00023.32, score=287.1]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=234, Expect=4e-61]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=234, Expect=4e-62]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=208, Expect=1e-53]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=187, Expect=7e-48]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=234, Expect=2e-63]} {RNA1509_19596} {RNA1310_2241.1} {RNA815_5124} |
28. | MligTC455_37105 | 54 | 1.13 | Mlig455_057732 | Neo: - Age: - |
ANGPTL1 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_057732 {REF} {Length: 2404} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=107.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.7, Expect=8e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=90.9, Expect=1e-19]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=92.8, Expect=2e-20]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=90.9, Expect=9e-20]} {Dmel: FBgn0050280, CG30280, [Score=88.6, Expect=6e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.6, Expect=2e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=85.1, Expect=5e-18]} {RNA1509_49031} {RNA1310_45132} {RNA815_44160} |
29. | MligTC455_48258 | 34 | 0.71 | Mlig455_020899 | Neo: - Age: Down-Down-Up |
VAV3 | 0.953 | - | - | - | - | - | 0.953 | Mlig455_020899 {REF} {Length: 3371} {Pfam: Calponin homology (CH) domain [PF00307.33, score=42.1]; RhoGEF domain [PF00621.22, score=39.9]; SH2 domain [PF00017.26, score=27.7]; CAMSAP CH domain [PF11971.10, score=19.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=18.8]} {Human: ENSG00000134215, VAV3, vav guanine nucleotide exchange factor 3, [Score=142, Expect=3e-34]; ENSG00000160293, VAV2, vav guanine nucleotide exchange factor 2, [Score=141, Expect=5e-34]} {Mouse: ENSMUSG00000009621, Vav2, vav 2 oncogene, [Score=140, Expect=6e-34]; ENSMUSG00000033721, Vav3, vav 3 oncogene, [Score=139, Expect=1e-33]} {Celegans: WBGene00006887, vav-1, [Score=109, Expect=4e-24]} {Smed: dd_Smed_v6_6109_0_1, dd_Smed_v6_6109_0_1, [Score=96.7, Expect=2e-20]} {RNA1310_24185} {RNA815_29420} |